The estimated Net Worth of Joshua Richardson is at least $9.62 Million dollars as of 31 January 2022. Joshua Richardson owns over 175,000 units of Sierra Oncology Inc stock worth over $9,623,250 and over the last 5 years Joshua sold SRRA stock worth over $0.
Joshua has made over 1 trades of the Sierra Oncology Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Joshua bought 175,000 units of SRRA stock worth $4,725,000 on 31 January 2022.
The largest trade Joshua's ever made was buying 175,000 units of Sierra Oncology Inc stock on 31 January 2022 worth over $4,725,000. On average, Joshua trades about 29,167 units every 0 days since 2019. As of 31 January 2022 Joshua still owns at least 175,000 units of Sierra Oncology Inc stock.
You can see the complete history of Joshua Richardson stock trades at the bottom of the page.
Joshua's mailing address filed with the SEC is C/O SIERRA ONCOLOGY, INC., 2150 - 885 WEST GEORGIA STREET, VANCOUVER, A1, V6C 3E8.
Over the last 8 years, insiders at Sierra Oncology Inc have traded over $0 worth of Sierra Oncology Inc stock and bought 8,528,701 units worth $69,515,388 . The most active insiders traders include Andrew Sinclair, Llp Abingworth, and James N Topper. On average, Sierra Oncology Inc executives and independent directors trade stock every 85 days with the average trade being worth of $21,400,348. The most recent stock trade was executed by William D. Turner on 5 April 2022, trading 6,447 units of SRRA stock currently worth $77,686.
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Sierra Oncology Inc executives and other stock owners filed with the SEC include: